Abstract

ObjectiveIschemic infarction of pituitary apoplexy (PA) is a rare type of pituitary apoplexy. This study aims to characterize ischemic PA via clinical presentations, imaging data, histopathological manifestations, and focus on the management and prognosis of the disease.MethodsThis study retrospectively identified 46 patients with ischemic PA confirmed using histopathology at a single institution from January 2013 to December 2020. The clinical presentations, imaging data, laboratory examination, management, and outcomes were collected. We then summarized the clinical presentations, imaging features, intraoperative findings, and histopathological manifestations, and compared the outcomes based on the timing of surgical intervention.ResultsHeadache was the most common initial symptom (95.65%, 44/46), followed by visual disturbance (89.13%, 41/46), and nausea and vomiting (58.70%, 27/46). 91.3% of the patients had at least one pituitary dysfunction, with hypogonadism being the most common endocrine dysfunction (84.78%, 39/46). Cortisol dysfunction occurred in 24 (52.17%) patients and thyroid dysfunction occurred in 17 (36.96%). Typical rim enhancement and thickening of the sphenoid sinus on MRI were seen in 35 (85.37%) and 26 (56.52%) patients, respectively. Except for one patient with asymptomatic apoplexy, the remaining patients underwent early (≤ 1 week, 12 patients) and delayed (> 1 week, 33 patients) transsphenoidal surgery. Total tumor resection was achieved in 27 patients and subtotal tumor resection in 19 patients. At surgery, cottage cheese–like necrosis was observed in 50% (23/46) of the patients. At the last follow-up of 5.5 ± 2.7 years, 92.68% (38/41) of the patients had gained a significant improvement in visual disturbance regardless of surgical timing, and 65% of the patients were still receiving long-term hormone replacement therapy.ConclusionPatients with ischemic PA can be accurately diagnosed by typical imaging characteristics preoperatively. The timing of surgical intervention does not significantly affect the resolution of neurological and endocrinological dysfunctions. Preoperative endocrine dysfunctions are common and usually appear to be poor after surgical intervention.

Highlights

  • Pituitary apoplexy (PA) is a rare, life-threatening emergency caused by hemorrhage and/or ischemia of a preexisting pituitary adenoma, and is most often a clinically non-functioning macroadenoma (Briet et al, 2015)

  • A total of 46 patients were diagnosed with ischemic PA, including 35 males and 11 females, with a male-to-female ratio of more than 3:1

  • Dopamine receptor agonists like bromocriptine, cabergoline, and somatostatin analogs were not seen in our study

Read more

Summary

Introduction

Pituitary apoplexy (PA) is a rare, life-threatening emergency caused by hemorrhage and/or ischemia of a preexisting pituitary adenoma, and is most often a clinically non-functioning macroadenoma (Briet et al, 2015). Compared with symptomatic pituitary apoplexy, approximately 25% of patients experienced asymptomatic pituitary apoplexy (Wakai et al, 1981; Fraioli et al, 1990; Onesti et al, 1990; Bonicki et al, 1993; Kinoshita et al, 2014)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call